Mologen, Synvolux, Federal Ministry of Education and Research deal

The companies partnered to develop a DNA vaccine to treat and prevent HBV infection using Mologen's MIDGE DNA vectors against HBV and Synvolux's SAINT transfection reagent as an adjuvant. Mologen sai...